Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX-2-selective agents?

Aliment Pharmacol Ther. 2018 Jul;48(1):108-110. doi: 10.1111/apt.14810.

Authors

C Scarpignato¹, C Blandizzi²

Affiliations

¹ Clinical Pharmacology & Digestive Pathophysiology Unit, Department of Clinical & Experimental Medicine, University of Parma, Parma, Italy.
² Pharmacology & Pharmacovigilance Unit, Department of Clinical & Experimental Medicine, University of Pisa, Pisa, Italy.

PMID: 29882981
DOI: 10.1111/apt.14810

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Drug Resistance, Microbial
Helicobacter pylori*
Humans

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Cyclooxygenase 2
Celecoxib